Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-035870
Filing Date
2022-06-10
Accepted
2022-06-10 16:18:16
Documents
2
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1507
2 POA DOCUMENT poa.txt EX-24 3869
  Complete submission text file 0001209191-22-035870.txt   6748
Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Issuer) CIK: 0001662774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIOXCEL THERAPEUTICS, INC. 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address
Bray June (Reporting) CIK: 0001845487 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38890 | Film No.: 221009143